Due to its role in the development of the inflammatory and immune responses, MCP-1 could be considered as an indicator that might allow the detection and quantification of the progression of ME/CFS. The gene discussed is CCL2; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.